KEY COMMUNICATIONS WITH REGULATORS, CONGRESS, AND THE ADMINISTRATION:
Healthy Markets regularly submits comment letters on regulatory filings and proposals. Here are the most recent -
Healthy Markets submits this Amicus brief to the US District Court arguing the merits of the IEX D-Limit order in a suit that was brought by Citadel.
Healthy Markets submits comments to the Securities and Exchange Commission objecting to Cboe’s efforts to limit its exchanges’ customers’ rights to recourse for past and future billing errors.
Healthy Markets submits comments to the Securities and Exchange Commission to enhance and adopt revisions to Regulation ATS and Regulation SCI for government securities ATSs.
Healthy Markets submits comments to the House Financial Services Committee for the hearing on February 18th entitled "Game Stopped? Who Wins and Loses When Short Sellers, Social Media, and Retail Investors Collide."
Healthy Markets joined a coalition of trade groups as the Biden-Harris Administration prepares to request critical economic stimulus legislation
from Congress, urging the Administration to stop any legislation in financial services or amendments to weaken the federal securities laws or exempt companies from those laws.
Healthy Markets, comments to the CFTC regarding a recent market data historical pricing increase imposed by the CME Futures exchange.
Healthy Markets, comments to the SEC on the Proposed Exemptive Order Granting Conditional Exemption from the Broker Registration Requirements of Section 15(a) of the Securities Exchange Act.
Together, Healthy Markets, The Council of Institutional Investors and the CFA Institute submit comments to the SEC regarding its proposed fund disclosures enhancements.
Healthy Markets submits comments to the SEC regarding the 7th filing by CBOE to raise connectivity fees.
Healthy Markets offers comments to the Ontario Securities Commission regarding the Capital Markets Modernization Taskforce Consultation Report.
Healthy Markets comments to the SEC regarding a proposal by the SEC on Reporting Thresholds for Institutional Investment Managers under 13F.
Healthy Markets supplements comments to the SEC regarding a proposal which seeks to modernize some aspects of the public market data stream.
Healthy Markets comments to the SEC regarding a proposal which seeks to modernize some aspects of the public market data stream.
Healthy Markets comments to the CFTC regarding a proposal which seeks to (1) implement a uniform 48-hour delay in reporting of all block trades, and (2) modify the definition of block trades.
Healthy Markets supplements comments to the SEC regarding a proposal by IEX to institute a new order-type called D-Limit.
Healthy Markets comments to the SEC on the CBOE exchange filing which seeks to increase connectivity fees.
Healthy Markets comments on Nasdaq's proposal to eliminate Unlisted Trading Priviledges via the SEC's inviation for exchanges to submit innovative proposals for thinly traded securities.
Healthy Markets comments to the CFTC on a proposal to implement a uniform 48-hour delay in
reporting of all block trades, and modify the definition of block trades.
Healthy Markets comments on proposals to modify the definition of an “accredited investor” and other efforts to modify the exemptions and exceptions to the registration and reporting requirements of the federal securities laws
Healthy Markets again submits comments to the SEC regarding a a second immediatly effective filing by NYSE National to establish fees for the NYSE National Integrated Market Data Feed.
Healthy Markets comments to the SEC regarding an immediatly effective filing by NYSE family of exchanges to establish new wireless connectivity fee offerings.
Healthy Markets comments to the CFTC on a proposal to prohibit the practice of post-trade name give-up on swaps that are anonymously executed on SEFs that are intended to be cleared.
Healthy Markets submits comments to the SEC regarding a filing by NMS Plan participants to develop a new data plan, enhance conflict disclosures and adopt confidentiality rules.
Healthy Markets submits comments to the SEC a proposal by IEX to institute a new order-type called D-Limit.
Healthy Markets submits comments to the SEC regarding an immediatly effective filing by NYSE National to establish fees for the NYSE National Integrated Market Data Feed.
Healthy Markets submits comments to the SEC regarding a proposal to provide revisions to market data plans under Regulation NMS.
Healthy Markets submits comments to the SEC regarding its proposal to remove immediate effectiveness from NMS Rule filings.
Healthy Markets submits comments regarding a filing by CBOE to link market data fees to volume.
Healthy Markets Executive Director Tyler Gellasch testifies before the SEC's Investor Advisory Committee on enhancing public markets. In the following video Mr. Gellasch's testimony begins at 3:01:22
Healthy Markets comments to the CTA/UTP plan operators request for comments regarding the inclusion of odd lots into the Securities Information Processor
Healthy Markets supplements comments regarding a FINRA proposal on Corporate Bond data.
Healthy Markets submits second comment letter to the SEC regarding a proposal by CBOE EDGA to introduce an asymmetric time delay on its market.
Healthy Markets comments to the SEC regarding its concept release on the harmonization of securities offering exemptions.
Healthy Market submits testimony to the House Financial Services Committee on the Public Versus Private market debate.
Healthy Market comments to the SEC regarding industry pushback to seek an additional extension to Rule 606 compliance.
Healthy Market comments on proposals by the BOX and MIAX exchanges regarding connectivity costs.
Healthy Market supplements comments to the SEC on a FINRA proposed Corporate Bond New Issue Reference Data Service.
Healthy Market comments on an SEC suspension order for a Cboe proposal to institute a Trading Rights Fee.
Healthy Market comments to the SEC on a Cboe proposal to institute an asymmetric delay on its EDGA exchange.
Healthy Market joins Council of Institutional Investors and CFA Institute in calling on the SEC to enhance disclosures of research practices.
Healthy Market comments on FINRA proposed change to establish a Pilot Program to study recommended changes to Corporate Bond Block Trade dissemination.
Healthy Market comments on FINRA proposed change to establish a Corporate Bond New Issue Reference Data Service.
Healthy Market supplements comments to the SEC regarding MiFID.
Healthy Market submits comment letter regarding MIAX Exchange connectivity fees (Release No. 34-85318).
Healthy Market submits comments to the SEC Investor Advisory Committee regarding MiFID II.
Healthy Market submits comments and Testimony to the SEC Investor Advisory Committee regarding the regulation of Exchanges.
Healthy Market submits third comment letter regarding BOX Exchange connectivity fees (Release No. 34-85201).
Healthy Market submits comments regarding odd lots to the SEC's Market Data and Market Access Rountable (Release No. 4-729).
Healthy Market submits third comment letter to SEC Chair Jay Clayton on issues related to MiFIDII.
Letter to Manisha Kimmel, Senior Policy Advisor, Securities and Exchange Commission regarding the Consolidated Audit Trail.
Letter to U.S. House Committee on Financial Services Chairwoman Maxine Waters and Ranking Member Patrick McHenry supporting H.R. 624
Letter to the Securities and Exchange Commission regarding BOX connectivity filings and related suspension orders.
Letter to the Securities and Exchange Commission Chairman Jay Clayton regarding recommendations on MiFID II and the SIFMA No-Action letter.
Letter to the Securities and Exchange Commission regarding NYSE's proposal to make the Retail Liquidity Pilot Program permanent.
Letter to the Securities and Exchange Commission Trading & Markets Director Brett Redfrearn with recommendations to bolster Order Handling Release
Letter to the Securities and Exchange Commission regarding Cboe EDGA pricing changes. Release No. 34-84599; File No. SR-CboeEDGA-2018-017
Letter to the Securities and Exchange Commission regarding NYSE Tier pricing filing. Release No. 34-84444; File No. SR-NYSE-2018-49
Statement and Comments to the Securities and Exchange Commission at the Market Data Roundtable.
Letter to the Securities and Exchange Commission regarding NYSE Tier pricing filing. Release No. 34-84097; File No. SR-NYSE-2018-40
Letter to the Securities and Exchange Commission regarding best execution standards for investment advisers. Release No. IA-4889; File No. S7-09-18
Letter to the Securities and Exchange Commission regarding a filing by CBOE to increase physical connectivity fees up to 25%.
Letter to the Securities and Exchange Commission regarding its transaction fee pilot proposal.
Letter to the Securities and Exchange Commission regarding TRACE reporting of treasuries.
Letter to the Securities and Exchange Commission regarding its transaction fee pilot proposal.
Testimony before the House Financial Services Committee, Subcommittee on Capital Markets, Securities, and Investment.
Letter to the Securities and Exchange Commission regarding market data reforms.
Letter to SEC Chairman Clayton, regarding implementation of MiFID II and impact on payments for research.
Letter to SEC Chairman Clayton et al, regarding market data reforms.
Testimony of Tyler Gellasch to the House Financial Services Committee on the Consolidated Audit Trail.
Letter to House Financial Services Committee Chairman Jeb Hensarling and Ranking Member Maxine Waters regarding capital formation bills, delays to the consolidated audit trail, and market structure reforms.
Letter to SEC Chairman Clayton regarding implementation of MiFID II and impact on payments for research.
Letter to Treasury Secretary regarding Presidential Report on Capital Markets Reforms.
Letter and statement to the House Financial Services Committee, Subcommittee on Capital Markets, Securities, and Investment, Hearing “U.S. Equity Market Structure Part I: A Review of the Evolution of Today’s Equity Market Structure and How We Got Here."
Comment letter to the SEC Chairman Clayton and SEC's Equity Market Structure Advisory Committee regarding market structure reforms and risks of "capital formation reforms".
Comment letter to the SEC's Equity Market Structure Advisory Committee regarding, Rule 611, Order Disclosure, NMS Plans and incentives.
Comment letter to the Securities and Exchange Commission regarding the Chicago Stock Exchange proposal to adopt a LEAD access delay.
Comment letter to the Securities and Exchange Commission regarding the Chicago Stock Exchange proposal to adopt a LEAD access delay.
Comment letter to the Securities and Exchange Commission regarding Order Handling Disclosure rules.
Comment letter to Securities and Exchange Commission regarding an Access Fee Pilot program.
Comment letter to the Securities and Exchange Commission regarding the CHX proposal for an access delay.
Comment letter to the Securities and Exchange Commission regarding the new proposal for Order Handling Disclosure rules.
Testimony before the SEC Equity Market Structure Advisory Committee regarding reforms to SEC Rules 605 and 606.
Proposal to SEC's Equity Market Structure Advisory Committee regarding NMS Market Making Standards.
Comment letter to the Securities and Exchange Commission regarding the proposed interpretation of "Automated Quotation."
Comment letter to the Securities and Exchange Commission regarding the synchronization tolerance for computer clocks.
Comment letter to the Securities and Exchange Commission regarding the Regulation of NMS Stock ATSs.
Comment letter to the Securities and Exchange Commission regarding IEX's Form 1 application for registration as an exchange.
Comment letter to the Securities and Exchange Commission regarding the composition and governance of the Equity Market Structure Advisory Committee.
Comment letter to the Financial Industry Regulatory Authority regarding clock synchronization.
Comment letter to the Securities and Exchange Commission regarding the Tick Size Pilot.
Comment letter to the Securities and Exchange Commission regarding accelerating data-driven regulation.